Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | S1PR5 | Q9H228 | 12/20 | 0.42 |
| ▸ | S1PR4 | O95977 | 10/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.37 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29307800 | 0.90 | CA1 (0.46) | CA1CA2ALOX5S1PR5S1PR4 | |
| SCHEMBL29307812 | 0.85 | MGLL (0.55) | CA1CA2ALOX5MGLL | |
| SCHEMBL10018879 | 0.85 | ALOX5 (0.50) | ALOX5S1PR5S1PR4HDAC4HDAC2 | |
| SCHEMBL29307809 | 0.85 | ALOX5 (0.41) | CA1CA2ALOX5HDAC8MGLL | |
| SCHEMBL29307811 | 0.84 | CA1 (0.51) | CA1CA2ALOX5S1PR5S1PR4 | |
| SCHEMBL29307810 | 0.84 | CA1 (0.58) | CA1CA2ALOX5S1PR5S1PR4 | |
| SCHEMBL20067350 | 0.83 | CA1 (0.62) | CA1CA2ALOX5HDAC4HDAC2 | |
| SCHEMBL21261165 | 0.81 | MGLL (0.50) | CA1CA2ALOX5MGLL | |
| SCHEMBL17167412 | 0.81 | ALOX5 (0.47) | ALOX5S1PR5S1PR4HDAC4HDAC2 | |
| SCHEMBL31512204 | 0.80 | MGLL (0.56) | CA1CA2ALOX5MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12041847-B2 | Compound for organic electric element, organic electric element using the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12041847-B2 | Compound for organic electric element, organic electric element using the same, and electronic device thereof | ORAI2, OR51E2, OR10J3 | CA1 1489/4885CA2 1330/4885ALOX5 820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.